🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/11/2001 | 4,53 | 4,60 | 4,48 | 4,50 | -0,55% | 2,76% | 482.800 |
| 29/11/2001 | 4,45 | 4,60 | 4,36 | 4,53 | +1,91% | 5,39% | 306.600 |
| 28/11/2001 | 4,60 | 4,63 | 4,40 | 4,44 | -3,48% | 4,89% | 354.400 |
| 27/11/2001 | 4,61 | 4,70 | 4,41 | 4,60 | +0,55% | 6,19% | 662.400 |
| 26/11/2001 | 4,59 | 4,64 | 4,46 | 4,58 | -1,51% | 3,93% | 224.400 |
| 23/11/2001 | 4,60 | 4,65 | 4,52 | 4,65 | -0,96% | 2,93% | 45.400 |
| 21/11/2001 | 4,69 | 4,74 | 4,54 | 4,69 | +0,00% | 4,37% | 329.400 |
| 20/11/2001 | 4,77 | 4,91 | 4,61 | 4,69 | -1,68% | 6,39% | 224.800 |
| 19/11/2001 | 4,91 | 4,95 | 4,70 | 4,77 | +0,42% | 4,99% | 343.400 |
| 16/11/2001 | 4,75 | 5,00 | 4,60 | 4,75 | +1,39% | 8,42% | 834.800 |
| 15/11/2001 | 4,68 | 4,75 | 4,64 | 4,69 | -0,11% | 2,25% | 302.400 |
| 14/11/2001 | 4,61 | 4,72 | 4,59 | 4,69 | +1,85% | 2,93% | 181.800 |
| 13/11/2001 | 4,58 | 4,65 | 4,57 | 4,61 | +0,11% | 1,86% | 115.800 |
| 12/11/2001 | 4,60 | 4,66 | 4,43 | 4,60 | -0,76% | 5,00% | 145.200 |
| 09/11/2001 | 4,66 | 4,73 | 4,58 | 4,64 | -0,64% | 3,33% | 197.800 |
| 08/11/2001 | 4,81 | 4,87 | 4,63 | 4,67 | -2,71% | 5,10% | 116.400 |
| 07/11/2001 | 4,83 | 4,98 | 4,79 | 4,80 | -0,72% | 3,94% | 137.600 |
| 06/11/2001 | 4,86 | 4,90 | 4,83 | 4,83 | -0,21% | 1,44% | 69.000 |
| 05/11/2001 | 4,78 | 4,90 | 4,70 | 4,84 | +1,89% | 4,19% | 118.600 |
| 02/11/2001 | 4,93 | 4,97 | 4,71 | 4,75 | -2,56% | 5,28% | 203.000 |
| 01/11/2001 | 4,70 | 4,90 | 4,55 | 4,88 | +3,17% | 7,45% | 633.000 |
| 31/10/2001 | 4,46 | 4,74 | 4,36 | 4,73 | +5,00% | 8,52% | 605.000 |
| 30/10/2001 | 4,45 | 4,56 | 4,42 | 4,50 | +0,33% | 3,15% | 174.400 |
| 29/10/2001 | 4,42 | 4,53 | 4,41 | 4,49 | +1,59% | 2,60% | 149.000 |
| 26/10/2001 | 4,50 | 4,57 | 4,41 | 4,42 | -1,89% | 3,67% | 164.200 |
| 25/10/2001 | 4,55 | 4,55 | 4,42 | 4,50 | -0,88% | 2,86% | 233.000 |
| 24/10/2001 | 4,58 | 4,62 | 4,40 | 4,54 | +0,22% | 4,70% | 235.800 |
| 23/10/2001 | 4,43 | 4,55 | 4,40 | 4,53 | +2,95% | 3,27% | 221.800 |
| 22/10/2001 | 4,50 | 4,54 | 4,40 | 4,40 | -2,33% | 3,00% | 407.600 |
| 19/10/2001 | 4,60 | 4,64 | 4,39 | 4,51 | +0,00% | 5,43% | 490.800 |